Award
National Cancer Institute 5P50CA097190-19
Project 3: Determining biomarkers for responsiveness to immunotherapy targeting LAG3/PD1 in HNSCC
Recipient
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Award Amount
$318,409.00
Ceiling
$318,409.00
Awarded
September 01, 2025
Identifier
5P50CA097190-19
Award for research to identify biomarkers for immunotherapy response in HNSCC targeting LAG3/PD1 pathways, managed by NCI and involving University of Pittsburgh investigators.
Description
This project focuses on identifying biomarkers for immunotherapy responsiveness in head and neck squamous cell carcinoma (HNSCC), with a particular emphasis on LAG3 and PD1 pathways. The award is managed by the National Cancer Institute, and the project involves multiple principal investigators from the University of Pittsburgh.